MOMO vs Navicare Biotech: monthly revenue

Monthly revenue and year-on-year change for MOMO (8454) and Navicare Biotech (8472) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ MOMO ━ Navicare Biotech

0%+202%-28%25/1026/0126/0426/0726/10

Monthly revenue history

MonthMOMOYoYNavicare BiotechYoY
Oct 2026NT$8.09 billion+3.8%NT$51.5 million+0.8%
Sep 2026NT$8.59 billion+8.2%NT$45.2 million-28.1%
Aug 2026NT$9.15 billion+7.8%NT$55.6 million+121.3%
Jul 2026NT$8.55 billion+5.2%NT$48.1 million+5.6%
Jun 2026NT$9.82 billion+6.5%NT$47.5 million-20.7%
May 2026NT$8.99 billion+4.1%NT$38.6 million+7.3%
Apr 2026NT$8.28 billion+1.3%NT$39.8 million-11.8%
Mar 2026NT$9.14 billion+2.1%NT$47.3 million+11.1%
Feb 2026NT$8.13 billion-2.1%NT$47 million+202.3%
Jan 2026NT$9.32 billion+1.9%NT$28.5 million+30.8%
Dec 2025NT$9.2 billion-5.7%NT$41.3 million+39.8%
Nov 2025NT$14.68 billion-5.7%NT$30.9 million-4.8%
Oct 2025NT$7.8 billion-4.4%NT$51 million+128.1%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16